{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:17:21Z","timestamp":1787728641445,"version":"build-2784847793"},"reference-count":56,"publisher":"SAGE Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JND"],"published-print":{"date-parts":[[2022,1,4]]},"abstract":"<jats:p>Background: GNE myopathy (GNEM) is a rare, adult-onset, inclusion body myopathy that results from mutations in the GNE gene. GNE encodes UDP-GlcNAc epimerase\/ManNAc-6 kinase, a protein with two enzymatic activities that comprise the committed step in biosynthesis of sialic acid (SA), an essential glycan that appears on the terminal positions of many extracellular oligosaccharide chains. These GNE mutations can cause a reduction of SA in many tissues, although pathology is restricted to skeletal muscles through a poorly understood mechanism. Objective: Despite recent advances in the field, it remains unclear which therapeutic avenue is most promising for the restoration of SA level in skeletal muscle affected by GNEM. Our objective was to assess dietary and gene therapy strategies for GNEM in Cmah-deficient GNED207VTgGne-\/- mice, a model that allows for the visualization of orally delivered N-glycolylneuraminic acid (Neu5Gc), one of the two predominant SA forms in muscle. Methods: Methods included in situ physiology studies of the tibialis anterior muscle, studies of ambulation and limb grip strength, and muscle staining using MAA, SNA, and anti-Neu5Gc antibody, along with qPCR, qRT-PCR, western blot, and HPLC studies to assess virally introduced DNA, GNE gene expression, GNE protein expression, and SA expression. Results: We found that a diet enriched in Neu5Gc-containing glycoproteins had no impact on Neu5Gc immunostaining in muscles of GNEM model mice. Delivery of a single high dose oral Neu5Gc therapy, however, did increase Neu5Gc immunostaining, though to levels below those found in wild type mice. Delivery of a single dose of GNE gene therapy using a recombinant Adeno Associated Virus (rAAV) vector with a liver-specific or a muscle-specific promoter both caused increased muscle Neu5Gc immunostaining that exceeded that seen with single dose monosaccharide therapy. Conclusions: Our findings indicate that dietary loading of Neu5Gc-containing glycoproteins is not effective in increasing muscle Neu5Gc expression, while single dose oral Neu5Gc monosaccharide or GNE gene therapy are. Neu5Gc immunostaining, however, showed greater changes than did lectin staining or HPLC analysis. Taken together, these results suggest that Neu5Gc immunostaining may be more sensitive technique to follow SA expression than other more commonly used methods and that liver expression of GNE may contribute overall muscle SA content.<\/jats:p>","DOI":"10.3233\/jnd-200575","type":"journal-article","created":{"date-parts":[[2021,9,10]],"date-time":"2021-09-10T13:19:30Z","timestamp":1631279970000},"page":"53-71","source":"Crossref","is-referenced-by-count":14,"title":["Visualizing Muscle Sialic Acid Expression in the GNED207VTgGne-\/- Cmah-\/- Model of GNE Myopathy: A Comparison of Dietary and Gene Therapy Approaches"],"prefix":"10.1177","volume":"9","author":[{"given":"Kelly E.","family":"Crowe","sequence":"first","affiliation":[{"name":"Department of Biology, Mount St. Joseph University Cincinnati, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah A.","family":"Zygmunt","sequence":"additional","affiliation":[{"name":"Center for Gene Therapy, Abigail Wexner Research Institute Children\u2019s Drive Columbus, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Heller","sequence":"additional","affiliation":[{"name":"Center for Gene Therapy, Abigail Wexner Research Institute Children\u2019s Drive Columbus, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Rodino-Klapac","sequence":"additional","affiliation":[{"name":"Center for Gene Therapy, Abigail Wexner Research Institute Children\u2019s Drive Columbus, OH, USA"},{"name":"Department of Pediatrics, The Ohio State University College of Medicine Columbus, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Noguchi","sequence":"additional","affiliation":[{"name":"Department of Neuromuscular Research, National Institute of Neuroscience Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichizo","family":"Nishino","sequence":"additional","affiliation":[{"name":"Department of Neuromuscular Research, National Institute of Neuroscience Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul T.","family":"Martin","sequence":"additional","affiliation":[{"name":"Center for Gene Therapy, Abigail Wexner Research Institute Children\u2019s Drive Columbus, OH, USA"},{"name":"Department of Pediatrics, The Ohio State University College of Medicine Columbus, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"issue":"4","key":"10.3233\/JND-200575_ref1","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1136\/jnnp-2013-307051","article-title":"GNE myopathy: Current update and future therapy","volume":"86","author":"Nishino","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.3233\/JND-200575_ref2","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/j.1471-4159.2007.05208.x","article-title":"Hyposialylation of neprilysin possibly affects its expression and enzymatic activity in hereditary inclusion-body myopathy muscle","volume":"105","author":"Broccolini","year":"2008","journal-title":"J Neurochem"},{"issue":"1","key":"10.3233\/JND-200575_ref3","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/ng718","article-title":"The UDP-N-acetylglucosamine 2-epimerase\/N-acetylmannosamine kinase gene is mutated in recessive hereditary inclusion body myopathy","volume":"29","author":"Eisenberg","year":"2001","journal-title":"Nat Genet"},{"issue":"39","key":"10.3233\/JND-200575_ref4","doi-asserted-by":"crossref","first-page":"24319","DOI":"10.1074\/jbc.272.39.24319","article-title":"A bifunctional enzyme catalyzes the first two steps in N-acetylneuraminic acid biosynthesis of rat liver. Molecular cloning and functional expression of UDP-N-acetyl-glucosamine 2-epimerase\/N-acetylmannosamine kinase","volume":"272","author":"Stasche","year":"1997","journal-title":"J Biol Chem"},{"key":"10.3233\/JND-200575_ref5","volume-title":"Essentials of Glycobiology","author":"Varki","year":"2009"},{"issue":"6","key":"10.3233\/JND-200575_ref6","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1086\/302411","article-title":"Mutations in the human UDP-N-acetylglucosamine 2-epimerase gene define the disease sialuria and the allosteric site of the enzyme","volume":"64","author":"Seppala","year":"1999","journal-title":"Am J Hum Genet"},{"issue":"39","key":"10.3233\/JND-200575_ref7","doi-asserted-by":"crossref","first-page":"24313","DOI":"10.1074\/jbc.272.39.24313","article-title":"A bifunctional enzyme catalyzes the first two steps in N-acetylneuraminic acid biosynthesis of rat liver. Purification and characterization of UDP-N-acetylglucosamine 2-epimerase\/N-acetylmannosamine kinase","volume":"272","author":"Hinderlich","year":"1997","journal-title":"J Biol Chem"},{"issue":"8","key":"10.3233\/JND-200575_ref8","doi-asserted-by":"crossref","first-page":"5267","DOI":"10.1073\/pnas.072066199","article-title":"Sialylation is essential for early development in mice","volume":"99","author":"Schwarzkopf","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"10.3233\/JND-200575_ref9","doi-asserted-by":"crossref","first-page":"13354","DOI":"10.18632\/oncotarget.7997","article-title":"Increased amyloid beta-peptide uptake in skeletal muscle is induced by hyposialylation and may account for apoptosis in GNE myopathy","volume":"7","author":"Bosch-Morato","year":"2016","journal-title":"Oncotarget"},{"issue":"3","key":"10.3233\/JND-200575_ref10","doi-asserted-by":"crossref","first-page":"e58116","DOI":"10.1371\/journal.pone.0058116","article-title":"Unfolded protein response and activated degradative pathways regulation in GNE myopathy","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"key":"10.3233\/JND-200575_ref11","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-2377-13-24","article-title":"Cell stress molecules in the skeletal muscle of GNE myopathy","volume":"13","author":"Fischer","year":"2013","journal-title":"BMC Neurol"},{"issue":"16","key":"10.3233\/JND-200575_ref12","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1093\/hmg\/ddx192","article-title":"Sialic acid deficiency is associated with oxidative stress leading to muscle atrophy and weakness in GNE myopathy","volume":"26","author":"Cho","year":"2017","journal-title":"Hum Mol Genet"},{"issue":"6","key":"10.3233\/JND-200575_ref13","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1172\/JCI30954","article-title":"Mutation in the key enzyme of sialic acid biosynthesis causes severe glomerular proteinuria and is rescued by N-acetylmannosamine","volume":"117","author":"Galeano","year":"2007","journal-title":"J Clin Invest"},{"issue":"1","key":"10.3233\/JND-200575_ref14","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s12017-012-8209-7","article-title":"Variable phenotypes of knockin mice carrying the M712T Gne mutation","volume":"15","author":"Sela","year":"2013","journal-title":"Neuromolecular Med"},{"issue":"4","key":"10.3233\/JND-200575_ref15","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.ymgme.2012.10.011","article-title":"Oral monosaccharide therapies to reverse renal and muscle hyposialylation in a mouse model of GNE myopathy","volume":"107","author":"Niethamer","year":"2012","journal-title":"Mol Genet Metab"},{"issue":"4","key":"10.3233\/JND-200575_ref16","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1074\/jbc.M111.297051","article-title":"Peracetylated N-acetylmannosamine, a synthetic sugar molecule, efficiently rescues muscle phenotype and biochemical defects in mouse model of sialic acid-deficient myopathy","volume":"287","author":"Malicdan","year":"2012","journal-title":"J Biol Chem"},{"issue":"2","key":"10.3233\/JND-200575_ref17","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1177\/1756285609359546","article-title":"A preclinical trial of sialic acid metabolites on distal myopathy with rimmed vacuoles\/hereditary inclusion body myopathy, a sugar-deficient myopathy: A review","volume":"3","author":"Malicdan","year":"2010","journal-title":"Ther Adv Neurol Disord"},{"issue":"1-2","key":"10.3233\/JND-200575_ref18","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ymgme.2017.04.010","article-title":"Safety, pharmacokinetics and sialic acid production after oral administration of N-acetylmannosamine (ManNAc) to subjects with GNE myopathy","volume":"122","author":"Xu","year":"2017","journal-title":"Mol Genet Metab"},{"issue":"18","key":"10.3233\/JND-200575_ref19","first-page":"e2109","article-title":"A phase 3 randomized study evaluating sialic acid extended-release for GNE myopathy","volume":"92","author":"Lochmuller","year":"2109","journal-title":"Neurology"},{"issue":"1","key":"10.3233\/JND-200575_ref20","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3233\/JND-159900","article-title":"Aceneuramic Acid Extended Release Administration Maintains Upper Limb Muscle Strength in a 48-week Study of Subjects with GNE Myopathy: Results from a Phase 2, Randomized, Controlled Study","volume":"3","author":"Argov","year":"2016","journal-title":"J Neuromuscul Dis"},{"issue":"6","key":"10.3233\/JND-200575_ref21","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/nm.1956","article-title":"Prophylactic treatment with sialic acid metabolites precludes the development of the myopathic phenotype in the DMRV-hIBM mouse model","volume":"15","author":"Malicdan","year":"2009","journal-title":"Nat Med"},{"issue":"11","key":"10.3233\/JND-200575_ref22","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1089\/hum.2010.192","article-title":"Hereditary inclusion body myopathy: Single patient response to intravenous dosing of GNE gene lipoplex","volume":"22","author":"Nemunaitis","year":"2011","journal-title":"Hum Gene Ther"},{"issue":"11","key":"10.3233\/JND-200575_ref23","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.nmd.2012.03.013","article-title":"Sustained expression and safety of human GNE in normal mice after gene transfer based on AAV8 systemic delivery","volume":"22","author":"Mitrani-Rosenbaum","year":"2012","journal-title":"Neuromuscul Disord"},{"issue":"Pt 10","key":"10.3233\/JND-200575_ref24","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1093\/brain\/awu210","article-title":"Sialyllactose ameliorates myopathic phenotypes in symptomatic GNE myopathy model mice","volume":"137","author":"Yonekawa","year":"2014","journal-title":"Brain"},{"issue":"1","key":"10.3233\/JND-200575_ref25","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1432-1033.1992.tb16925.x","article-title":"Mouse liver cytidine-5\u2019-monophosphate-N-acetylneuraminic acid hydroxylase. Catalytic function and regulation","volume":"206","author":"Shaw","year":"1992","journal-title":"Eur J Biochem"},{"issue":"12","key":"10.3233\/JND-200575_ref26","doi-asserted-by":"crossref","first-page":"4340","DOI":"10.1128\/MCB.00379-07","article-title":"N-glycolylneuraminic acid deficiency in mice: Implications for human biology and evolution","volume":"27","author":"Hedlund","year":"2007","journal-title":"Mol Cell Biol"},{"issue":"20","key":"10.3233\/JND-200575_ref27","doi-asserted-by":"crossref","first-page":"11751","DOI":"10.1073\/pnas.95.20.11751","article-title":"A mutation in human CMP-sialic acid hydroxylase occurred after the Homo-Pan divergence","volume":"95","author":"Chou","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.3233\/JND-200575_ref28","doi-asserted-by":"crossref","first-page":"e88226","DOI":"10.1371\/journal.pone.0088226","article-title":"A Comparative Study of N-glycolylneuraminic Acid (Neu5Gc) and Cytotoxic T Cell (CT) Carbohydrate Expression in Normal and Dystrophin-Deficient Dog and Human Skeletal Muscle","volume":"9","author":"Martin","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.3233\/JND-200575_ref29","doi-asserted-by":"crossref","first-page":"e4241","DOI":"10.1371\/journal.pone.0004241","article-title":"Sensitive and specific detection of the non-human sialic Acid N-glycolylneuraminic acid in human tissues and biotherapeutic products","volume":"4","author":"Diaz","year":"2009","journal-title":"PLoS ONE"},{"issue":"6","key":"10.3233\/JND-200575_ref30","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.4049\/jimmunol.1601471","article-title":"Loss of CMAH during Human Evolution Primed the Monocyte-Macrophage Lineage toward a More Inflammatory and Phagocytic State","volume":"198","author":"Okerblom","year":"2017","journal-title":"J Immunol"},{"issue":"7222","key":"10.3233\/JND-200575_ref31","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nature07428","article-title":"Incorporation of a non-human glycan mediates human susceptibility to a bacterial toxin","volume":"456","author":"Byres","year":"2008","journal-title":"Nature"},{"issue":"36","key":"10.3233\/JND-200575_ref32","doi-asserted-by":"crossref","first-page":"12819","DOI":"10.1073\/pnas.0503819102","article-title":"Evolution of human-chimpanzee differences in malaria susceptibility: Relationship to human genetic loss of N-glycolylneuraminic acid","volume":"102","author":"Martin","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.3233\/JND-200575_ref33","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.virol.2013.02.009","article-title":"Canine and feline parvoviruses preferentially recognize the non-human cell surface sialic acid N-glycolylneuraminic acid","volume":"440","author":"Lofling","year":"2013","journal-title":"Virology"},{"issue":"48","key":"10.3233\/JND-200575_ref34","doi-asserted-by":"crossref","first-page":"18936","DOI":"10.1073\/pnas.0803943105","article-title":"Evidence for a human-specific mechanism for diet and antibody-mediated inflammation in carcinoma progression","volume":"105","author":"Hedlund","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10.3233\/JND-200575_ref35","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1158\/0008-5472.CAN-10-4102","article-title":"Human xeno-autoantibodies against a non-human sialic acid serve as novel serum biomarkers and immunotherapeutics in cancer","volume":"71","author":"Padler-Karavani","year":"2011","journal-title":"Cancer Res"},{"issue":"6","key":"10.3233\/JND-200575_ref36","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1096\/fj.10-175281","article-title":"Pancreatic beta-cell failure in obese mice with human-like CMP-Neu5Ac hydroxylase deficiency","volume":"25","author":"Kavaler","year":"2011","journal-title":"FASEB J"},{"issue":"32","key":"10.3233\/JND-200575_ref37","doi-asserted-by":"crossref","first-page":"16036","DOI":"10.1073\/pnas.1902902116","article-title":"Human species-specific loss of CMP-N-acetylneuraminic acid hydroxylase enhances atherosclerosis via intrinsic and extrinsic mechanisms","volume":"116","author":"Kawanishi","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.3233\/JND-200575_ref38","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1093\/glycob\/cwt020","article-title":"N-Glycolylneuraminic acid deficiency worsens cardiac and skeletal muscle pathophysiology in alpha-sarcoglycan-deficient mice","volume":"23","author":"Martin","year":"2013","journal-title":"Glycobiology"},{"issue":"42","key":"10.3233\/JND-200575_ref39","doi-asserted-by":"crossref","first-page":"42ra54","DOI":"10.1126\/scitranslmed.3000692","article-title":"A human-specific deletion in mouse Cmah increases disease severity in the mdx model of Duchenne muscular dystrophy","volume":"2","author":"Chandrasekharan","year":"2010","journal-title":"Sci Transl Med"},{"key":"10.3233\/JND-200575_ref40","doi-asserted-by":"crossref","unstructured":"Okerblom J , Fletes W , Patel HH , Schenk S , Varki A , Breen EC . Human-like Cmah inactivation in mice increases running endurance and decreases muscle fatigability: Implications for human evolution. Proc Biol Sci. 2018;285(1886).","DOI":"10.1098\/rspb.2018.1656"},{"issue":"22","key":"10.3233\/JND-200575_ref41","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1093\/hmg\/ddm220","article-title":"A Gne knockout mouse expressing human GNE D176V mutation develops features similar to distal myopathy with rimmed vacuoles or hereditary inclusion body myopathy","volume":"16","author":"Malicdan","year":"2007","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JND-200575_ref42","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13395-014-0028-0","article-title":"A role for Galgt1 in skeletal muscle regeneration","volume":"5","author":"Singhal","year":"2015","journal-title":"Skelet Muscle"},{"key":"10.3233\/JND-200575_ref43","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.omtm.2021.02.004","article-title":"Micro-laminin gene therapy can function as an inhibitor of muscle disease in the dy(W) mouse model of MDC1A","volume":"21","author":"Packer","year":"2021","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"41","key":"10.3233\/JND-200575_ref44","doi-asserted-by":"crossref","first-page":"8914","DOI":"10.1021\/bi201050u","article-title":"Identification, tissue distribution, and molecular modeling of novel human isoforms of the key enzyme in sialic acid synthesis, UDP-GlcNAc 2-epimerase\/ManNAc kinase","volume":"50","author":"Yardeni","year":"2011","journal-title":"Biochemistry"},{"issue":"3","key":"10.3233\/JND-200575_ref45","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1128\/JVI.72.3.2224-2232.1998","article-title":"Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus","volume":"72","author":"Xiao","year":"1998","journal-title":"J Virol"},{"issue":"6","key":"10.3233\/JND-200575_ref46","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/sj.gt.3300938","article-title":"Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield","volume":"6","author":"Zolotukhin","year":"1999","journal-title":"Gene Ther"},{"issue":"4","key":"10.3233\/JND-200575_ref47","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/mt.2013.246","article-title":"Vascular delivery of rAAVrh74.MCK.GALGT2 to the gastrocnemius muscle of the rhesus macaque stimulates the expression of dystrophin and laminin alpha2 surrogates","volume":"22","author":"Chicoine","year":"2014","journal-title":"Mol Ther"},{"issue":"4","key":"10.3233\/JND-200575_ref48","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"1","key":"10.3233\/JND-200575_ref49","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/mus.21198","article-title":"Embryonic overexpression of Galgt2 inhibits skeletal muscle growth via activation of myostatin signaling","volume":"39","author":"Chandraskeharan","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.3233\/JND-200575_ref50","doi-asserted-by":"crossref","unstructured":"Camboni M , Wang CM , Miranda C , Yoon JH , Xu R , Zygmunt D , et al. Active and passive immunization strategies based on the SDPM1 peptide demonstrate pre-clinical efficacy in the APPswePSEN1dE9 mouse model for Alzheimer\u2019s disease. Neurobiol Dis. 2013.","DOI":"10.1016\/j.nbd.2013.09.001"},{"issue":"4","key":"10.3233\/JND-200575_ref51","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0896-6273(00)80974-5","article-title":"Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins","volume":"19","author":"Borchelt","year":"1997","journal-title":"Neuron"},{"issue":"21","key":"10.3233\/JND-200575_ref52","doi-asserted-by":"crossref","first-page":"12045","DOI":"10.1073\/pnas.2131556100","article-title":"Human uptake and incorporation of an immunogenic nonhuman dietary sialic acid","volume":"100","author":"Tangvoranuntakul","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"34","key":"10.3233\/JND-200575_ref53","doi-asserted-by":"crossref","first-page":"28852","DOI":"10.1074\/jbc.M112.364182","article-title":"Metabolism of vertebrate amino sugars with N-glycolyl groups: Mechanisms underlying gastrointestinal incorporation of the non-human sialic acid xeno-autoantigen N-glycolylneuraminic acid","volume":"287","author":"Banda","year":"2012","journal-title":"J Biol Chem"},{"issue":"3","key":"10.3233\/JND-200575_ref54","doi-asserted-by":"crossref","first-page":"e0173261","DOI":"10.1371\/journal.pone.0173261","article-title":"Substantial deficiency of free sialic acid in muscles of patients with GNE myopathy and in a mouse model","volume":"12","author":"Chan","year":"2017","journal-title":"PLoS One"},{"issue":"7","key":"10.3233\/JND-200575_ref55","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1073\/pnas.96.7.3906","article-title":"Sustained correction of bleeding disorder in hemophilia B mice by gene therapy","volume":"96","author":"Wang","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.3233\/JND-200575_ref56","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/sj.mt.6300027","article-title":"Design of tissue-specific regulatory cassettes for high-level rAAV-mediated expression in skeletal and cardiac muscle","volume":"15","author":"Salva","year":"2007","journal-title":"Mol Ther"}],"container-title":["Journal of Neuromuscular Diseases"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JND-200575","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T23:49:52Z","timestamp":1777506592000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JND-200575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,4]]},"references-count":56,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3233\/jnd-200575","relation":{},"ISSN":["2214-3599","2214-3602"],"issn-type":[{"value":"2214-3599","type":"print"},{"value":"2214-3602","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,4]]}}}